Marks, D. I. & Rowntree, C. Management of adults with T-cell lymphoblastic leukemia. Blood. 129, 1134–1142 (2017).

CAS  Article  Google Scholar 

Rodriguez-Zuniga, M. J. M., Cortez-Franco, F. & Qujiano-Gomero, E. Adult T-cell leukemia/lymphoma. Review of the literature. Actas Dermosifiliogr (Engl Ed) 109, 399–407 (2018).

CAS  Google Scholar 

Brown, C. E. & Mackall, C. L. CAR T cell therapy: inroads to response and resistance. Nat. Rev. Immunol. 19, 73–74 (2019).

CAS  Article  Google Scholar 

MacKay, M. et al. The therapeutic landscape for cells engineered with chimeric antigen receptors. Nat. Biotechnol. 38, 233–244 (2020).

CAS  Article  Google Scholar 

Neelapu, S. S. et al. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N. Engl. J. Med. 377, 2531–2544 (2017).

CAS  Article  Google Scholar 

Maude, S. L. et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N. Engl. J. Med. 378, 439–448 (2018).

CAS  Article  Google Scholar 

Abramson, J. S. et al. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study. Lancet 396, 839–852 (2020).

Article  Google Scholar 

Depil, S., Duchateau, P., Grupp, S. A., Mufti, G. & Poirot, L. ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges. Nat. Rev. Drug Discov. 19, 185–199 (2020).

CAS  Article  Google Scholar 

Mo, F., Mamonkin, M., Brenner, M. K. & Heslop, H. E. Taking T-cell oncotherapy off-the-shelf. Trends Immunol. 42, 261–272 (2021).

CAS  Article  Google Scholar 

Benjamin, R. et al. Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies. Lancet 396, 1885–1894 (2020).

CAS  Article  Google Scholar 

Hu, Y. et al. CRISPR/Cas9-engineered universal CD19/CD22 dual-targeted CAR-T cell therapy for relapsed/refractory B-cell acute lymphoblastic leukemia. Clin. Cancer Res. 27, 2764–2772 (2021).

CAS  Article  Google Scholar 

Fleischer, L. C., Spencer, H. T. & Raikar, S. S. Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions. J. Hematol. Oncol. 12, 141 (2019).

Article  Google Scholar 

Campana, D. et al. Stages of T-cell receptor protein expression in T-cell acute lymphoblastic leukemia. Blood 77, 1546–1554 (1991).

CAS  Article  Google Scholar 

Gomes-Silva, D. et al. CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood 130, 285–296 (2017).

CAS  Article  Google Scholar 

Pan, J. et al. Donor-derived CD7 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia: first-in-Human, phase I trial. J. Clin. Oncol. 39, 3340–3351 (2021).

CAS  Article  Google Scholar 

Lu, P. et al. Naturally selected CD7 CAR-T therapy without genetic manipulations for T-ALL/LBL: first-in-human phase I clinical trial. Blood 140, 321–334 (2022).

Li, S. et al. Eradication of T-ALL cells by CD7-targeted universal CAR-T cells and initial test of ruxolitinib-based CRS management. Clin. Cancer Res. 27, 1242–1246 (2021).

CAS  Article  Google Scholar 

Chou, C. K. & Turtle, C. J. Assessment and management of cytokine release syndrome and neurotoxicity following CD19 CAR-T cell therapy. Expert Opin. Biol. Ther. 20, 653–664 (2020).

CAS  Article  Google Scholar 

Rosshart, S. et al. Interaction of KLRG1 with E-cadherin: new functional and structural insights. Eur. J. Immunol. 38, 3354–3364 (2008).

CAS  Article  Google Scholar 

Jung, L. K., Roy, A. K. & Chakkalath, H. R. CD7 augments T cell proliferation via the interleukin-2 autocrine pathway. Cell. Immunol. 141, 189–199 (1992).

CAS  Article  Google Scholar 

Yee, C. et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells. Proc. Natl. Acad. Sci USA 99, 16168–16173 (2002).

CAS  Article  Google Scholar 

Nata, T. et al. Targeting the binding interface on a shared receptor subunit of a cytokine family enables the inhibition of multiple member cytokines with selectable target spectrum. J. Biol. Chem. 290, 22338–22351 (2015).

CAS  Article  Google Scholar 

Chang, H., Yeung, J., Brandwein, J. & Yi, Q. L. CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype. Leuk. Res. 31, 157–162 (2007).

CAS  Article  Google Scholar 

Gomes-Silva, D. et al. CD7 CAR T cells for the therapy of acute myeloid leukemia. Mol. Ther. 27, 272–280 (2019).

CAS  Article  Google Scholar 

Heslop, H. E. How I treat EBV lymphoproliferation. Blood 114, 4002–4008 (2009).

CAS  Article  Google Scholar 

Fraietta, J. A. et al. Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nat. Med. 24, 563–571 (2018).

CAS  Article  Google Scholar 

Kagoya, Y. et al. A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects. Nat. Med. 24, 352–359 (2018).

CAS  Article  Google Scholar 

Xu, Y. et al. 2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies. J. Hematol. Oncol. 12, 49 (2019).

Article  Google Scholar 

Mamonkin, M. et al. Reversible transgene expression reduces fratricide and permits 4-1BB costimulation of CAR T cells directed to T-cell malignancies. Cancer Immunol. Res. 6, 47–58 (2018).

CAS  Article  Google Scholar 

Maciocia, P. M. et al. Targeting the T cell receptor beta-chain constant region for immunotherapy of T cell malignancies. Nat. Med. 23, 1416–1423 (2017).

CAS  Article  Google Scholar 

Mamonkin, M., Rouce, R. H., Tashiro, H. & Brenner, M. K. A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood 126, 983–992 (2015).

CAS  Article  Google Scholar 

Hsu, C. et al. Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood 109, 5168–5177 (2007).

CAS  Article  Google Scholar 

Kim, M. Y. et al. CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy. JCI Insight 6, e149819 (2021).

Greco, A. et al. Altered urinary excretion of human kininase activity in hypertension. Adv. Exp. Med. Biol. 120B, 645–649 (1979).

CAS  PubMed  Google Scholar